Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Hong

Showing results (131-140 of 442) with videos related to

Pageof 45
Sort By:
Clinical Genitourinary Cancer|June 25, 2011
Retrospective analysis of satraplatin in patients with metastatic urothelial cancer refractory to standard platinum-based chemotherapyMatthew D Galsky, Sonia Seng, Luis H Camacho, et al.
Cancer Chemotherapy and Pharmacology|January 31, 2016
Phase I clinical trial of lenalidomide in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with advanced cancerRabih Said, Yang Ye, David S Hong, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|July 22, 2014
Aberrant parietal cortex developmental trajectories in girls with Turner syndrome and related visual-spatial cognitive development: a preliminary studyTamar Green, Lindsay C Chromik, Paul K Mazaika, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2020
Mogamulizumab in Combination with Durvalumab or Tremelimumab in Patients with Advanced Solid Tumors: A Phase I StudyDmitriy Zamarin, Omid Hamid, Asha Nayak-Kapoor, et al.
Biological Psychiatry|September 29, 2019
Brain Development in School-Age and Adolescent Girls: Effects of Turner Syndrome, Estrogen Therapy, and Genomic ImprintingStefani O'Donoghue, Tamar Green, Judith L Ross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2010
Patients with advanced head and neck cancers have similar progression-free survival on phase I trials and their last food and drug administration-approved treatmentIgnacio Garrido-Laguna, Filip Janku, Gerald S Falchook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2011
Outcome analyses after the first admission to an intensive care unit in patients with advanced cancer referred to a phase I clinical trials programSiqing Fu, David S Hong, Aung Naing, et al.
Oncotarget|December 20, 2014
A phase 1b, open-label study of trebananib plus bevacizumab or motesanib in patients with solid tumoursDavid S Hong, Razelle Kurzrock, Marilyn Mulay, et al.
Cancer Medicine|December 5, 2025
Predicting Benefit of Neoadjuvant Chemotherapy and Elective Nodal Irradiation in Pancreatic Adenocarcinoma: A Supervised Machine Learning ApproachGarrett K Harada, Jino Park, Nicholas Peterson, et al.
Cancer|May 4, 2011
Prevalence of complementary medicine use in a phase 1 clinical trials program: the MD Anderson Cancer Center ExperienceAung Naing, Saneese K Stephen, Moshe Frenkel, et al.
Pageof 45

Showing results (131-140 of 442) with videos related to

Sort By:
Pageof 45
Clinical Genitourinary Cancer|June 25, 2011
Retrospective analysis of satraplatin in patients with metastatic urothelial cancer refractory to standard platinum-based chemotherapyMatthew D Galsky, Sonia Seng, Luis H Camacho, et al.
Cancer Chemotherapy and Pharmacology|January 31, 2016
Phase I clinical trial of lenalidomide in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with advanced cancerRabih Said, Yang Ye, David S Hong, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|July 22, 2014
Aberrant parietal cortex developmental trajectories in girls with Turner syndrome and related visual-spatial cognitive development: a preliminary studyTamar Green, Lindsay C Chromik, Paul K Mazaika, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2020
Mogamulizumab in Combination with Durvalumab or Tremelimumab in Patients with Advanced Solid Tumors: A Phase I StudyDmitriy Zamarin, Omid Hamid, Asha Nayak-Kapoor, et al.
Biological Psychiatry|September 29, 2019
Brain Development in School-Age and Adolescent Girls: Effects of Turner Syndrome, Estrogen Therapy, and Genomic ImprintingStefani O'Donoghue, Tamar Green, Judith L Ross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2010
Patients with advanced head and neck cancers have similar progression-free survival on phase I trials and their last food and drug administration-approved treatmentIgnacio Garrido-Laguna, Filip Janku, Gerald S Falchook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2011
Outcome analyses after the first admission to an intensive care unit in patients with advanced cancer referred to a phase I clinical trials programSiqing Fu, David S Hong, Aung Naing, et al.
Oncotarget|December 20, 2014
A phase 1b, open-label study of trebananib plus bevacizumab or motesanib in patients with solid tumoursDavid S Hong, Razelle Kurzrock, Marilyn Mulay, et al.
Cancer Medicine|December 5, 2025
Predicting Benefit of Neoadjuvant Chemotherapy and Elective Nodal Irradiation in Pancreatic Adenocarcinoma: A Supervised Machine Learning ApproachGarrett K Harada, Jino Park, Nicholas Peterson, et al.
Cancer|May 4, 2011
Prevalence of complementary medicine use in a phase 1 clinical trials program: the MD Anderson Cancer Center ExperienceAung Naing, Saneese K Stephen, Moshe Frenkel, et al.
Pageof 45